Your session is about to expire
← Back to Search
Early Aggressive vs Traditional Therapy for Multiple Sclerosis (TREAT-MS Trial)
TREAT-MS Trial Summary
This trial will help researchers understand if an early aggressive therapy approach is better than a traditional first-line therapy approach for preventing long-term disability in MS patients.
TREAT-MS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTREAT-MS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TREAT-MS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are HIV negative.You meet 2017 McDonald criteria for relapsing-remitting MS.I don't have JC virus, hepatitis B or C, or tuberculosis.I am between 18 and 60 years old.I haven't had chemotherapy in the last year and if I had cancer before, my doctor has noted why stronger treatment is needed.
- Group 1: Early Aggressive Therapy
- Group 2: Traditional Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 84 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment available for this experiment?
"Affirmative. According to the clinicaltrials.gov database, this medical experiment is still searching for participants, with initial postings beginning on May 2nd 2018 and recent updates occurring October 10th 2022. The trial aims to enroll 900 patients across 41 disparate sites nationwide."
Up to what point will this trial accept new participants?
"To successfully complete this medical research, 900 volunteers should be recruited who meet the predetermined eligibility criteria. These individuals can sign up at Billings Clinic in Montana or Icahn School of Medicine at Mount Sinai in NYC."
Is it possible for me to sign up for this medical experiment?
"To be enrolled in this clinical trial, applicants must have multiple sclerosis, acute relapsing and fall under the age of 60. This medical study is recruiting 900 participants in total."
Can individuals younger than 55 years old partake in this trial?
"The cut-off age for this trial is 60 years old, with the minimum being 18."
What ultimate outcome is this trial attempting to achieve?
"The primary outcome of this trial, measured over a span of up to 75 months from randomization, is the Change in Overall Burden of MS. Supporting metrics include Marital Status (incident divorce/separation), Employment Status (change to disabled or unemployed), and Multiple sclerosis Functional Composite score (a z-score derived from timed walk tests)."
What number of medical facilities are participating in this trial?
"Currently, Billings Clinic in Montana, Icahn School of Medicine at Mount Sinai in New york City, and Medical College of Wisconsin in Milwaukee are partaking as clinical trial sites. Additionally, 41 other facilities across the US are included among these enrolment points."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger